共 50 条
- [41] Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer [J]. British Journal of Cancer, 2006, 95 : 1250 - 1257
- [42] Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening [J]. DRUG HEALTHCARE AND PATIENT SAFETY, 2013, 5 : 1 - 2
- [46] COMPARISON OF CYTOLOGY AND CERVICOGRAPHY IN SCREENING A HIGH-RISK AUSTRALIAN POPULATION FOR CERVICAL HUMAN PAPILLOMAVIRUS AND CERVICAL INTRAEPITHELIAL NEOPLASIA [J]. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1993, 33 (02): : 176 - 179
- [48] High-Risk and Low-Risk Human Papillomavirus and the Absolute Risk of Cervical Intraepithelial Neoplasia or Cancer [J]. OBSTETRICS AND GYNECOLOGY, 2014, 123 (01): : 57 - 64
- [49] Long-term outcomes of high-risk human papillomavirus infection support a long interval of cervical cancer screening [J]. British Journal of Cancer, 2008, 98 : 863 - 869